ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Toxicity Testing Reorganization Announced; Rall To Head It Up

November 17, 1978

Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors

May 15, 1992

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981

CCOP Review Committees Listed

February 6, 1987

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006